210 related articles for article (PubMed ID: 6439836)
1. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
[TBL] [Abstract][Full Text] [Related]
2. Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
Moertel CG; Lavin PT
Cancer Treat Rep; 1979; 63(11-12):1863-9. PubMed ID: 393381
[TBL] [Abstract][Full Text] [Related]
3. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
[TBL] [Abstract][Full Text] [Related]
4. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
[TBL] [Abstract][Full Text] [Related]
5. Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1979; 63(11-12):1871-6. PubMed ID: 393382
[TBL] [Abstract][Full Text] [Related]
6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
7. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.
Levi JA; Fox RM; Tattersall MH; Woods RL; Thomson D; Gill G
J Clin Oncol; 1986 Sep; 4(9):1348-55. PubMed ID: 3528404
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
10. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.
Wils J; Bleiberg H; Dalesio O; Blijham G; Mulder N; Planting A; Splinter T; Duez N
J Clin Oncol; 1986 Dec; 4(12):1799-803. PubMed ID: 3783204
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
Coombes RC; Schein PS; Chilvers CE; Wils J; Beretta G; Bliss JM; Rutten A; Amadori D; Cortes-Funes H; Villar-Grimalt A
J Clin Oncol; 1990 Aug; 8(8):1362-9. PubMed ID: 2199622
[TBL] [Abstract][Full Text] [Related]
12. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
Gibson MK; Holcroft CA; Kvols LK; Haller D
Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Haim N; Epelbaum R; Cohen Y; Robinson E
Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group.
Cancer; 1984 Jan; 53(1):13-7. PubMed ID: 6418371
[TBL] [Abstract][Full Text] [Related]
17. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
[No Abstract] [Full Text] [Related]
18. 5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Coltman C; Bottomley R; Wilson H; Bonnet J; Thigpen T; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1978 Sep; 42(3):1228-33. PubMed ID: 359121
[TBL] [Abstract][Full Text] [Related]
19. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; RodinĂ² C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group.
De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
Recent Results Cancer Res; 1988; 110():212-8. PubMed ID: 3136519
[No Abstract] [Full Text] [Related]
[Next] [New Search]